Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ImmunityBio, Inc. (IBRX)
USD7.86
+0.07 (+0.90%)
US NASDAQ Healthcare Biotechnology
Address
3530 John Hopkins Court 92121
San Diego, CA, US
San Diego, CA, US
CEO
Richard Gerald Adcock
Website
immunitybio.com
IPO
2015-07-28
CIK 1326110 ISIN US45256X1037
Description
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| IB | NK | 2021-01-19 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD7.86
+0.07 (+0.90%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
14M
Beta
0.10
Float Shares
113.84M
Free Float %
10.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.70% | +3.71% | +11.40% | +22.51% | +293.69% | +309.60% | +243.64% | +255.70% | -46.61% | +19.79% | -76.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
7.86
Low
12.00
+52.7%
Consensus
13.00
+65.4%
Median
12.00
+52.7%
High
15.00
+90.8%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
12.00
+52.7%
|
| Last Quarter | 3 |
13.00
+65.4%
|
| Last Year | 4 |
11.50
+46.3%
|
| All Time | 6 |
10.00
+27.2%
|
Quality scores
Altman Z-Score
-6.19
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+668.3% ★ Q1'26: +167.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+38.7% ★ Q1'26: -313.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-347.9% Q1'26: -174.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-211.0% Q1'26: -157.9% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-176.2% Q1'26: +222.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+31.3% Q1'26: +20.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-3.93× Q1'26: -4.30× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
236.0K
est: 850.7K (-72.3%)
|
44.0K
est: 88.0K (-50.0%)
|
45.0K
est: 41.0K (+9.8%)
|
47.0K
est: 44.0K (+6.8%)
|
43.0K
est: 100.0K (-57.0%)
|
605.0K
est: 105.0K (+476.2%)
|
934.0K
est: 569.0K (+64.1%)
|
240.0K
est: 192.0K (+25.0%)
|
622.0K
est: 302.0K (+106.0%)
|
14.75M
est: 21.23M (-30.5%)
|
113.29M
est: 113.30M (0.0%)
|
219.11M
214.07M – 224.13M
+93.4% YoY
|
518.37M
337.84M – 698.91M
+136.6% YoY
|
1.20B
822.54M – 1.56B
+131.2% YoY
|
2.22B
1.52B – 2.90B
+85.3% YoY
|
3.74B
2.56B – 4.87B
+68.3% YoY
|
| EBITDA |
-235.71M
est: -850.7K (-27,608.3%)
|
-117.71M
est: -88.0K (-133,659.1%)
|
-90.73M
est: -41.0K (-221,197.6%)
|
-86.74M
est: -44.0K (-197,038.6%)
|
-56.86M
est: -100.0K (-56,755.0%)
|
-204.22M
est: -105.0K (-194,395.2%)
|
-320.75M
est: -569.0K (-56,271.2%)
|
-351.88M
est: -192.0K (-183,171.4%)
|
-478.66M
est: -302.0K (-158,397.7%)
|
-264.43M
est: -21.23M (-1,145.9%)
|
-223.56M
est: -113.30M (-97.3%)
|
-219.11M
-224.13M – -214.07M
-93.4% YoY
|
-518.37M
-698.91M – -337.84M
-136.6% YoY
|
-1.20B
-1.56B – -822.54M
-131.2% YoY
|
-2.22B
-2.90B – -1.52B
-85.3% YoY
|
-3.74B
-4.87B – -2.56B
-68.3% YoY
|
| EBIT |
-237.18M
est: -850.7K (-27,781.3%)
|
-121.32M
est: -88.0K (-137,758.0%)
|
-96.30M
est: -41.0K (-234,773.2%)
|
-96.30M
est: -44.0K (-218,754.5%)
|
-65.87M
est: -100.0K (-65,767.0%)
|
-216.96M
est: -105.0K (-206,527.6%)
|
-334.99M
est: -569.0K (-58,773.5%)
|
-370.14M
est: -192.0K (-192,681.8%)
|
-497.18M
est: -302.0K (-164,527.5%)
|
-281.99M
est: -21.23M (-1,228.6%)
|
-239.08M
est: -113.30M (-111.0%)
|
-219.11M
-224.13M – -214.07M
-93.4% YoY
|
-518.37M
-698.91M – -337.84M
-136.6% YoY
|
-1.20B
-1.56B – -822.54M
-131.2% YoY
|
-2.22B
-2.90B – -1.52B
-85.3% YoY
|
-3.74B
-4.87B – -2.56B
-68.3% YoY
|
| Net Income |
-236.88M
est: -1.31B (+81.9%)
|
-120.81M
est: -1.13B (+89.4%)
|
-96.42M
est: -854.54M (+88.7%)
|
-96.23M
est: -923.36M (+89.6%)
|
-65.79M
est: -518.33M (+87.3%)
|
-221.85M
est: -539.34M (+58.9%)
|
-346.79M
est: -945.60M (+63.3%)
|
-416.57M
est: -700.44M (+40.5%)
|
-583.20M
est: -600.96M (+3.0%)
|
-413.56M
est: -731.89M (+43.5%)
|
-351.40M
est: -355.07M (+1.0%)
|
-559.37M
-577.42M – -541.32M
-57.5% YoY
|
-47.77M
-76.44M – -19.11M
+91.5% YoY
|
447.67M
415.70M – 479.64M
+1,037.1% YoY
|
1.02B
604.68M – 1.42B
+128.1% YoY
|
1.82B
1.08B – 2.54B
+78.1% YoY
|
| SGA |
226.21M
est: 154.90M (+46.0%)
|
94.39M
est: 16.02M (+489.0%)
|
53.82M
est: 7.47M (+620.9%)
|
35.46M
est: 8.01M (+342.6%)
|
9.05M
est: 18.21M (-50.3%)
|
71.32M
est: 19.12M (+273.0%)
|
135.26M
est: 103.61M (+30.5%)
|
102.71M
est: 34.96M (+193.8%)
|
129.62M
est: 47.95M (+170.3%)
|
168.78M
est: 3.37B (-95.0%)
|
147.18M
est: 17.99B (-99.2%)
|
34.79B
33.99B – 35.59B
+93.4% YoY
|
82.31B
53.64B – 110.97B
+136.6% YoY
|
190.29B
130.60B – 248.11B
+131.2% YoY
|
352.60B
242.00B – 459.73B
+85.3% YoY
|
593.38B
407.25B – 773.65B
+68.3% YoY
|
| EPS |
-0.73
est: -1.87 (+61.0%)
|
-0.37
est: -1.62 (+77.2%)
|
-0.30
est: -1.22 (+75.4%)
|
-0.30
est: -1.32 (+77.2%)
|
-0.42
est: -0.74 (+43.2%)
|
-0.59
est: -0.77 (+23.4%)
|
-0.89
est: -1.35 (+34.1%)
|
-1.04
est: -1.00 (-4.0%)
|
-1.15
est: -1.05 (-9.0%)
|
-0.59
est: -0.80 (+26.3%)
|
-0.38
est: -0.39 (+1.6%)
|
-0.61
-0.63 – -0.59
-57.5% YoY
|
-0.05
-0.08 – -0.02
+91.2% YoY
|
0.49
0.45 – 0.52
+1,011.0% YoY
|
1.11
0.66 – 1.55
+128.1% YoY
|
1.98
1.17 – 2.76
+78.1% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | D. Boral Capital | Buy | Buy | Maintain |
| 2026-04-21 | D. Boral Capital | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
518.78M
OE per share TTM
0.54
Owner's Yield
5.94%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
745.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
135
Total invested
74.80M
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 5.62M | 6.92% | 5.62M | — | 5.62M | — | CO | USA | 2016-02-17 | ↗ |
| 2 | dividing (a) the total number of shares of the Issuer’s common stock being reported in this Statemen | 4.69M | 12.00% | 4.69M | — | 4.69M | — | IN | United States | 2018-02-13 | ↗ |
| 3 | 2. | 4.49M | 5.50% | — | — | — | 4.49M | OO | United States | 2016-02-12 | ↗ |
| 4 | Sorrento Therapeutics, Inc. | — | 0.00% | — | — | — | — | CO | Delaware | 2017-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
135
-148 vs prev Q
New positions
54
Closed positions
193
Increased
97
Reduced
18
Put/Call ratio
0.00
Calls held
1.0K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 264.6K +264.6K (+100.0%) | 523.82M +523.8M (+100.0%) | 0.03% +0.028 pp | 0.21% +0.207 pp | USD1.98 +0.0% | 1 qtrs NEW |
| 2 | VANGUARD GROUP INC | 32.78M +5.1M (+18.5%) | 64.90M -3.1M (-4.6%) | 3.46% +0.349 pp | 0.00% 0.000 pp | USD5.41 -63.4% | 20 qtrs — |
| 3 | BLACKROCK, INC. | 25.60M +5.8M (+29.2%) | 50.69M +2.0M (+4.0%) | 2.70% +0.474 pp | 0.00% +0.000 pp | USD2.96 -33.1% | 6 qtrs — |
| 4 | STATE STREET CORP | 16.46M +5.1M (+45.4%) | 32.58M +4.7M (+17.0%) | 1.74% +0.464 pp | 0.00% +0.000 pp | USD3.53 -43.9% | 20 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 7.92M +1.0M (+15.0%) | 15.68M -1.3M (-7.5%) | 0.84% +0.061 pp | 0.00% 0.000 pp | USD5.90 -66.4% | 20 qtrs — |
| 6 | GOLDMAN SACHS GROUP INC | 6.15M +5.0M (+439.4%) | 12.18M +9.4M (+334.1%) | 0.65% +0.522 pp | 0.00% +0.001 pp | USD2.39 -17.2% | 20 qtrs — |
| 7 | MORGAN STANLEY | 5.11M +1.7M (+51.4%) | 10.11M +1.8M (+21.8%) | 0.54% +0.160 pp | 0.00% +0.000 pp | USD2.85 -30.5% | 20 qtrs — |
| 8 | TWO SIGMA INVESTMENTS, LP | 4.72M +2.1M (+80.9%) | 9.34M +2.9M (+45.6%) | 0.50% +0.205 pp | 0.01% +0.004 pp | USD2.28 -13.2% | 5 qtrs — |
| 9 | WOODLINE PARTNERS LP | 3.45M -1.9M (-34.9%) | 6.82M -6.2M (-47.6%) | 0.36% -0.232 pp | 0.03% -0.035 pp | USD2.83 -30.0% | 7 qtrs — |
| 10 | ALPHACORE CAPITAL LLC | 3.00M +12.0K (+0.4%) | 5.94M -1.4M (-19.2%) | 0.32% -0.020 pp | 0.13% -0.115 pp | USD2.64 -25.0% | 3 qtrs — |
| 11 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.50M +202.2K (+8.8%) | 4.95M -703.4K (-12.4%) | 0.26% +0.005 pp | 0.00% 0.000 pp | USD5.93 -66.6% | 20 qtrs — |
| 12 | BARCLAYS PLC | 2.44M +2.1M (+577.0%) | 4.84M +3.5M (+260.3%) | 0.26% +0.218 pp | 0.00% +0.001 pp | USD2.17 -8.8% | 16 qtrs — |
| 13 | BANK OF AMERICA CORP /DE/ | 2.38M +727.7K (+44.0%) | 4.72M +646.6K (+15.9%) | 0.25% +0.065 pp | 0.00% +0.000 pp | USD2.48 -20.2% | 20 qtrs — |
| 14 | TANG CAPITAL MANAGEMENT LLC | 2.33M +— (+0.0%) | 4.62M -1.1M (-19.5%) | 0.25% -0.016 pp | 0.23% +0.007 pp | USD2.56 -22.7% | 5 qtrs — |
| 15 | NORTHERN TRUST CORP | 2.23M +225.8K (+11.3%) | 4.42M -514.9K (-10.4%) | 0.24% +0.010 pp | 0.00% 0.000 pp | USD6.63 -70.1% | 20 qtrs — |
| 16 | KERCHEVILLE ADVISORS, LLC | 584.2K +65.1K (+12.5%) | 4.29M +3.0M (+235.8%) | 0.06% +0.003 pp | 1.12% +0.738 pp | USD2.44 -18.9% | 3 qtrs — |
| 17 | UBS GROUP AG | 2.00M +315.0K (+18.7%) | 3.95M -182.9K (-4.4%) | 0.21% +0.022 pp | 0.00% +0.000 pp | USD2.87 -31.0% | 20 qtrs — |
| 18 | VOLEON CAPITAL MANAGEMENT LP | 1.51M +1.5M (+9,218.2%) | 3.00M +3.0M (+7,400.0%) | 0.16% +0.158 pp | 0.06% +0.064 pp | USD1.99 -0.5% | 2 qtrs — |
| 19 | SQUAREPOINT OPS LLC | 1.49M +481.4K (+47.5%) | 2.96M +466.8K (+18.7%) | 0.16% +0.044 pp | 0.00% +0.001 pp | USD2.31 -14.3% | 2 qtrs — |
| 20 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 1.32M +— (+0.0%) | 2.62M -629.3K (-19.4%) | 0.14% -0.009 pp | 0.01% -0.003 pp | USD3.05 -35.1% | 8 qtrs — |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 1.23M +215.6K (+21.2%) | 2.44M -60.9K (-2.4%) | 0.13% +0.016 pp | 0.00% +0.001 pp | USD2.38 -16.8% | 2 qtrs — |
| 22 | JPMORGAN CHASE & CO | 1.22M +161.9K (+15.3%) | 2.42M -187.2K (-7.2%) | 0.13% +0.010 pp | 0.00% +0.000 pp | USD10.59 -81.3% | 20 qtrs — |
| 23 | TWO SIGMA ADVISERS, LP | 1.14M +1.0M (+870.8%) | 2.26M +2.0M (+681.4%) | 0.12% +0.107 pp | 0.00% +0.004 pp | USD2.03 -2.5% | 2 qtrs — |
| 24 | BANK OF NEW YORK MELLON CORP | 882.3K +123.5K (+16.3%) | 1.75M -119.6K (-6.4%) | 0.09% +0.008 pp | 0.00% 0.000 pp | USD7.39 -73.2% | 20 qtrs — |
| 25 | CLEARWATER CAPITAL ADVISORS, LLC | 845.1K -1.3K (-0.2%) | 1.67M -408.9K (-19.6%) | 0.09% -0.006 pp | 0.14% -0.038 pp | USD5.18 -61.8% | 20 qtrs — |
| 26 | GROUP ONE TRADING, L.P. | 766.9K -391.9K (-33.8%) | 1.52M -1.3M (-46.7%) | 0.08% -0.049 pp | 0.00% -0.002 pp | USD2.72 -27.2% | 5 qtrs — |
| 27 | CITADEL ADVISORS LLC | 704.6K -426.2K (-37.7%) | 1.40M -1.4M (-49.8%) | 0.07% -0.053 pp | 0.00% 0.000 pp | USD2.90 -31.7% | 8 qtrs — |
| 28 | ALLEN HOLDING INC /NY | 687.6K +— (+0.0%) | 1.36M -330.0K (-19.5%) | 0.07% -0.005 pp | 0.13% -0.030 pp | USD14.28 -86.1% | 19 qtrs — |
| 29 | ACCURATE WEALTH MANAGEMENT, LLC | 560.0K +— (+0.0%) | 1.30M -100.8K (-7.2%) | 0.06% -0.004 pp | 0.17% -0.022 pp | USD6.27 -68.4% | 7 qtrs — |
| 30 | SWISS NATIONAL BANK | 652.4K +138.9K (+27.0%) | 1.29M +28.5K (+2.3%) | 0.07% +0.011 pp | 0.00% +0.000 pp | USD5.69 -65.2% | 20 qtrs — |
| 31 | NUVEEN, LLC | 633.1K +125.1K (+24.6%) | 1.25M +3.9K (+0.3%) | 0.07% +0.010 pp | 0.00% +0.000 pp | USD2.70 -26.7% | 4 qtrs — |
| 32 | SHEETS SMITH WEALTH MANAGEMENT | 632.0K -1.1K (-0.2%) | 1.25M -306.1K (-19.7%) | 0.07% -0.005 pp | 0.14% -0.039 pp | USD5.39 -63.3% | 20 qtrs — |
| 33 | SCULPTOR CAPITAL LP | 620.0K +— (+0.0%) | 1.23M -297.6K (-19.5%) | 0.07% -0.004 pp | 0.01% -0.005 pp | USD2.82 -29.8% | 14 qtrs — |
| 34 | RAFFERTY ASSET MANAGEMENT, LLC | 607.3K +154.9K (+34.2%) | 1.20M +89.5K (+8.0%) | 0.06% +0.013 pp | 0.00% +0.001 pp | USD3.25 -39.1% | 9 qtrs — |
| 35 | DEKABANK DEUTSCHE GIROZENTRALE | 196.2K +— (+0.0%) | 1.17M +668.0K (+134.4%) | 0.02% -0.001 pp | 0.00% +0.001 pp | USD7.15 -72.3% | 19 qtrs — |
| 36 | JANE STREET GROUP, LLC | 530.4K -51.3K (-8.8%) | 1.05M -380.8K (-26.6%) | 0.06% -0.010 pp | 0.00% 0.000 pp | USD2.80 -29.3% | 6 qtrs — |
| 37 | WELLS FARGO & COMPANY/MN | 515.9K +245.7K (+90.9%) | 1.02M +356.7K (+53.7%) | 0.05% +0.024 pp | 0.00% +0.000 pp | USD2.95 -32.9% | 20 qtrs — |
| 38 | SIMPLEX TRADING, LLC | 493.4K +454.0K (+1,149.5%) | 977.0K +880.0K (+907.2%) | 0.05% +0.048 pp | 0.00% +0.001 pp | USD2.03 -2.5% | 3 qtrs — |
| 39 | UBS ASSET MANAGEMENT AMERICAS INC | 461.2K +38.3K (+9.1%) | 913.1K -127.0K (-12.2%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD3.80 -47.9% | 20 qtrs — |
| 40 | LPL FINANCIAL LLC | 458.1K -161.2K (-26.0%) | 907.0K -616.5K (-40.5%) | 0.05% -0.021 pp | 0.00% 0.000 pp | USD2.98 -33.6% | 10 qtrs — |
| 41 | QUADRATURE CAPITAL LTD | 436.9K +174.5K (+66.5%) | 865.0K +222.1K (+34.6%) | 0.05% +0.017 pp | 0.01% +0.001 pp | USD2.27 -12.8% | 2 qtrs — |
| 42 | HENNION & WALSH ASSET MANAGEMENT, INC. | 402.6K +95.9K (+31.2%) | 797.2K +42.5K (+5.6%) | 0.04% +0.008 pp | 0.03% +0.000 pp | USD2.43 -18.5% | 3 qtrs — |
| 43 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 367.9K +205.5K (+126.6%) | 728.4K +328.9K (+82.3%) | 0.04% +0.021 pp | 0.01% +0.002 pp | USD2.19 -9.6% | 2 qtrs — |
| 44 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 355.9K -822.2K (-69.8%) | 704.7K -2.2M (-75.7%) | 0.04% -0.095 pp | 0.00% 0.000 pp | USD3.20 -38.1% | 20 qtrs — |
| 45 | ALLIANCEBERNSTEIN L.P. | 350.5K -8.7K (-2.4%) | 694.0K -189.6K (-21.5%) | 0.04% -0.003 pp | 0.00% 0.000 pp | USD5.94 -66.7% | 20 qtrs — |
| 46 | RHUMBLINE ADVISERS | 327.6K +13.0K (+4.1%) | 648.6K -125.3K (-16.2%) | 0.03% -0.001 pp | 0.00% 0.000 pp | USD6.96 -71.6% | 20 qtrs — |
| 47 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 317.1K +68.2K (+27.4%) | 627.9K +15.4K (+2.5%) | 0.03% +0.006 pp | 0.00% +0.000 pp | USD5.72 -65.4% | 20 qtrs — |
| 48 | CLEARSTEAD ADVISORS, LLC | 311.7K +38.7K (+14.2%) | 617.2K -54.4K (-8.1%) | 0.03% +0.002 pp | 0.01% -0.001 pp | USD4.82 -58.9% | 7 qtrs — |
| 49 | LEGAL & GENERAL GROUP PLC | 292.5K +69.6K (+31.2%) | 579.1K +30.8K (+5.6%) | 0.03% +0.006 pp | 0.00% +0.000 pp | USD3.98 -50.3% | 20 qtrs — |
| 50 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 290.6K +220.3K (+313.4%) | 575.0K +402.0K (+232.4%) | 0.03% +0.023 pp | 0.00% +0.001 pp | USD2.13 -7.0% | 13 qtrs — |
| 51 | VIRTUS INVESTMENT ADVISERS, INC. | 289.6K +150.3K (+107.9%) | 573.4K +230.7K (+67.3%) | 0.03% +0.015 pp | 0.16% +0.058 pp | USD2.45 -19.2% | 4 qtrs — |
| 52 | PLANCORP, LLC | 271.5K -2.0 (0.0%) | 537.5K -130.3K (-19.5%) | 0.03% -0.002 pp | 0.02% -0.005 pp | USD2.64 -25.0% | 3 qtrs — |
| 53 | LMR PARTNERS LLP | 260.0K -342.4K (-56.8%) | 514.8K -967.1K (-65.3%) | 0.03% -0.040 pp | 0.00% -0.006 pp | USD2.91 -32.0% | 11 qtrs — |
| 54 | WINNING POINTS ADVISORS, LLC | 722.4K +722.4K (+100.0%) | 509.0K +509.0K (+100.0%) | 0.08% +0.076 pp | 0.54% +0.544 pp | USD1.98 +0.0% | 1 qtrs NEW |
| 55 | BLAIR WILLIAM & CO/IL | 240.2K +— (+0.0%) | 475.6K -115.3K (-19.5%) | 0.03% -0.002 pp | 0.00% 0.000 pp | USD4.91 -59.7% | 20 qtrs — |
| 56 | ADVISOR GROUP HOLDINGS, INC. | 225.1K -2.4K (-1.0%) | 445.7K -88.6K (-16.6%) | 0.02% -0.002 pp | 0.00% 0.000 pp | USD3.64 -45.6% | 20 qtrs — |
| 57 | PROFUND ADVISORS LLC | 224.7K +127.1K (+130.3%) | 444.9K +204.9K (+85.4%) | 0.02% +0.013 pp | 0.01% +0.006 pp | USD2.72 -27.2% | 9 qtrs — |
| 58 | DEUTSCHE BANK AG\ | 219.8K +33.5K (+18.0%) | 435.3K -23.1K (-5.0%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD3.85 -48.6% | 20 qtrs — |
| 59 | RAYMOND JAMES FINANCIAL INC | 211.2K -28.3K (-11.8%) | 418.2K -170.9K (-29.0%) | 0.02% -0.005 pp | 0.00% 0.000 pp | USD2.58 -23.3% | 5 qtrs — |
| 60 | CI PRIVATE WEALTH, LLC | 186.4K -9.9K (-5.1%) | 369.0K -113.9K (-23.6%) | 0.02% -0.002 pp | 0.00% 0.000 pp | USD3.27 -39.4% | 13 qtrs — |
| 61 | INVESCO LTD. | 182.8K +23.4K (+14.6%) | 362.0K -30.3K (-7.7%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD3.48 -43.1% | 20 qtrs — |
| 62 | CANADA PENSION PLAN INVESTMENT BOARD | 172.8K +172.8K (+100.0%) | 342.1K +342.1K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD1.98 +0.0% | 1 qtrs NEW |
| 63 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 172.5K +41.3K (+31.5%) | 341.5K +16.3K (+5.0%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD4.21 -53.0% | 7 qtrs — |
| 64 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 168.1K +18.8K (+12.6%) | 332.8K -34.5K (-9.4%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD6.49 -69.5% | 20 qtrs — |
| 65 | METLIFE INVESTMENT MANAGEMENT, LLC | 164.3K +40.8K (+33.0%) | 325.2K +21.5K (+7.1%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD3.05 -35.1% | 20 qtrs — |
| 66 | RATHBONES GROUP PLC | 161.4K +— (+0.0%) | 319.6K -77.5K (-19.5%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD2.17 -8.8% | 10 qtrs — |
| 67 | PRIVATE ADVISOR GROUP, LLC | 161.1K +148.2K (+1,153.3%) | 318.9K +287.3K (+908.8%) | 0.02% +0.016 pp | 0.00% +0.001 pp | USD2.31 -14.3% | 9 qtrs — |
| 68 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 160.5K -5.2K (-3.1%) | 317.8K -89.8K (-22.0%) | 0.02% -0.002 pp | 0.02% -0.009 pp | USD4.00 -50.5% | 14 qtrs — |
| 69 | PRICE T ROWE ASSOCIATES INC /MD/ | 158.2K +37.2K (+30.7%) | 314.0K +16.0K (+5.4%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD7.64 -74.1% | 20 qtrs — |
| 70 | ERSTE ASSET MANAGEMENT GMBH | 153.0K +— (+0.0%) | 312.1K -81.1K (-20.6%) | 0.02% -0.001 pp | 0.00% -0.001 pp | USD5.02 -60.6% | 9 qtrs — |
| 71 | LOS ANGELES CAPITAL MANAGEMENT LLC | 132.2K +132.2K (+100.0%) | 312.1K +312.1K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.001 pp | USD1.98 +0.0% | 1 qtrs NEW |
| 72 | COLLECTIVE FAMILY OFFICE LLC | 156.8K -4.5K (-2.8%) | 310.5K -86.2K (-21.7%) | 0.02% -0.002 pp | 0.07% -0.024 pp | USD4.29 -53.8% | 7 qtrs — |
| 73 | HANDELSBANKEN FONDER AB | 144.8K +48.8K (+50.8%) | 287.0K +51.0K (+21.6%) | 0.02% +0.005 pp | 0.00% +0.000 pp | USD3.75 -47.2% | 7 qtrs — |
| 74 | SBI SECURITIES CO., LTD. | 119.3K +6.0K (+5.3%) | 236.3K -42.5K (-15.2%) | 0.01% 0.000 pp | 0.01% -0.001 pp | USD2.60 -23.8% | 5 qtrs — |
| 75 | JANUS HENDERSON GROUP PLC | 118.7K +— (+0.0%) | 234.5K -57.0K (-19.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.73 -27.5% | 15 qtrs — |
| 76 | MILLENNIUM MANAGEMENT LLC | 118.4K +70.1K (+145.2%) | 234.5K +115.7K (+97.4%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD2.29 -13.5% | 20 qtrs — |
| 77 | B. RILEY WEALTH ADVISORS, INC. | 113.0K +— (+0.0%) | 223.7K -54.2K (-19.5%) | 0.01% -0.001 pp | 0.01% -0.003 pp | USD2.64 -25.0% | 3 qtrs — |
| 78 | STATE OF NEW JERSEY COMMON PENSION FUND D | 112.9K +112.9K (+100.0%) | 223.6K +223.6K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.001 pp | USD1.98 +0.0% | 1 qtrs NEW |
| 79 | LIDO ADVISORS, LLC | 111.1K +— (+0.0%) | 220.0K -53.3K (-19.5%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD2.64 -25.0% | 3 qtrs — |
| 80 | CITIGROUP INC | 110.5K -2.3M (-95.4%) | 218.8K -5.6M (-96.3%) | 0.01% -0.257 pp | 0.00% -0.003 pp | USD3.05 -35.1% | 20 qtrs — |
| 81 | INTECH INVESTMENT MANAGEMENT LLC | 109.2K -9.0K (-7.7%) | 216.1K -74.7K (-25.7%) | 0.01% -0.002 pp | 0.00% -0.001 pp | USD3.12 -36.5% | 6 qtrs — |
| 82 | SOWELL FINANCIAL SERVICES LLC | 103.7K +6.0 (+0.0%) | 205.3K -49.8K (-19.5%) | 0.01% -0.001 pp | 0.01% -0.002 pp | USD2.46 -19.5% | 2 qtrs — |
| 83 | REGIONS FINANCIAL CORP | 102.0K +— (+0.0%) | 202.0K -49.0K (-19.5%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD2.64 -25.0% | 3 qtrs — |
| 84 | PROSHARE ADVISORS LLC | 97.4K +24.4K (+33.5%) | 192.9K +13.3K (+7.4%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD6.52 -69.6% | 20 qtrs — |
| 85 | MERIDIAN INVESTMENT COUNSEL INC. | 96.4K +— (+0.0%) | 190.9K -46.3K (-19.5%) | 0.01% -0.001 pp | 0.05% -0.013 pp | USD23.74 -91.7% | 20 qtrs — |
| 86 | WEALTH EFFECTS LLC | 93.0K -21.5K (-18.8%) | 184.1K -97.5K (-34.6%) | 0.01% -0.003 pp | 0.06% -0.033 pp | USD3.84 -48.4% | 16 qtrs — |
| 87 | ARIZONA STATE RETIREMENT SYSTEM | 92.2K +14.0K (+17.9%) | 182.5K -9.9K (-5.1%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD5.88 -66.3% | 20 qtrs — |
| 88 | KESTRA ADVISORY SERVICES, LLC | 89.8K +27.9K (+45.1%) | 177.9K +25.6K (+16.8%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD2.74 -27.7% | 11 qtrs — |
| 89 | FRANKLIN RESOURCES INC | 87.1K -68.0 (-0.1%) | 172.4K -42.0K (-19.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.64 -25.0% | 8 qtrs — |
| 90 | HSBC HOLDINGS PLC | 86.1K +— (+0.0%) | 168.4K -42.2K (-20.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.63 -24.7% | 8 qtrs — |
| 91 | NATIONAL BANK OF CANADA /FI/ | 84.7K -22.7K (-21.1%) | 167.7K -96.5K (-36.5%) | 0.01% -0.003 pp | 0.00% 0.000 pp | USD2.48 -20.2% | 17 qtrs — |
| 92 | STATE OF WISCONSIN INVESTMENT BOARD | 83.5K -4.3K (-4.9%) | 165.4K -50.7K (-23.5%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD5.78 -65.7% | 20 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 111 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck Social Sentiment ETF BUZZ | 3.51% | 3.52M | 0.76% |
| 2 | iShares Genomics Immunology and Healthcare ETF IDNA | 3.40% | 6.66M | 0.47% |
| 3 | Trenchless Fund ETF RVER | 3.22% | 3.96M | 0.65% |
| 4 | Pinnacle Focused Opportunities ETF FCUS | 2.61% | 2.27M | 0.81% |
| 5 | Xtrackers - MSCI Pakistan Swap UCITS ETF XBAK.L | 2.45% | 568.0K | 0.85% |
| 6 | Virtus Biotech ETF BBP | 1.49% | 1.47M | 0.34% |
| 7 | Global X - S&P Biotech ETF CURE.AX | 0.95% | 342.0K | 0.45% |
| 8 | State Street SPDR S&P Biotech ETF XBI | 0.95% | 102.99M | 0.35% |
| 9 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.59% | 444.0K | 0.19% |
| 10 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.59% | 2.74M | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.43
Bearish
Ratio by volume
2.79
Bullish
Buys
13
Sells
30
Shares acquired
5.67M
Shares disposed
2.03M
Cash buys
—
Cash sales
8.00
Net activity
+3,637,010
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 4,606,596 | 5.43 | 25.00M | 251,018,873 | I | ↗ |
| 2026-02-24 | Simon Barry J. | Director | S-Sale | D | Common Stock | 75,000 | 12.01 | 900.8K | 2,850,821 | D | ↗ |
| 2026-02-23 | Simon Barry J. | Director | S-Sale | D | Common Stock | 165,000 | 10.25 | 1.69M | 2,925,821 | D | ↗ |
| 2026-02-23 | Selecky Christobel | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 2.98 | 74.5K | 67,937 | D | ↗ |
| 2026-02-22 | Simon Barry J. | Director | M-Exempt | D | Restricted Stock Units | 15,243 | 0.00 | — | 15,245 | D | ↗ |
| 2026-02-22 | Sachs David C. | Officer | M-Exempt | D | Restricted Stock Units | 40,650 | 0.00 | — | 40,651 | D | ↗ |
| 2026-02-22 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | M-Exempt | D | Restricted Stock Units | 114,329 | 0.00 | — | 114,329 | D | ↗ |
| 2026-02-22 | LAUER REGAN J | Officer | M-Exempt | D | Restricted Stock Units | 4,065 | 0.00 | — | 4,065 | D | ↗ |
| 2026-02-22 | Adcock Richard | Director / Officer | M-Exempt | D | Restricted Stock Units | 152,439 | 0.00 | — | 152,439 | D | ↗ |
| 2026-02-20 | Simon Barry J. | Director | S-Sale | D | Common Stock | 10,000 | 9.25 | 92.5K | 3,081,604 | D | ↗ |
| 2026-02-10 | Sachs David C. | Officer | M-Exempt | D | Restricted Stock Units | 82,236 | 0.00 | — | 164,474 | D | ↗ |
| 2026-02-10 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | M-Exempt | D | Restricted Stock Units | 274,122 | 0.00 | — | 548,246 | D | ↗ |
| 2026-02-10 | LAUER REGAN J | Officer | F-InKind | D | Common Stock | 2,257 | 6.93 | 15.6K | 113,483 | D | ↗ |
| 2026-02-10 | Adcock Richard | Director / Officer | F-InKind | D | Common Stock | 140,048 | 6.93 | 970.5K | 485,465 | D | ↗ |
| 2026-01-20 | Simon Barry J. | Director | S-Sale | D | Common Stock | 76,967 | 6.54 | 503.4K | 3,166,604 | D | ↗ |
| 2026-01-20 | Selecky Christobel | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 2.98 | 74.5K | 92,937 | D | ↗ |
| 2026-01-16 | Selecky Christobel | Director | M-Exempt | D | Stock Option (right to buy) | 50,000 | 2.98 | 149.0K | 117,937 | D | ↗ |
| 2025-12-31 | Sachs David C. | Officer | M-Exempt | D | Restricted Stock Units | 30,397 | 0.00 | — | 45,602 | D | ↗ |
| 2025-12-31 | Adcock Richard | Director / Officer | M-Exempt | D | Restricted Stock Units | 34,483 | 0.00 | — | 51,731 | D | ↗ |
| 2025-12-12 | Wendel Bruce | Director | A-Award | A | Stock Option (right to buy) | 146,020 | 2.36 | 344.6K | 146,020 | D | ↗ |
| 2025-06-18 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 162,786 | 2.84 | 462.3K | 162,786 | D | ↗ |
| 2025-06-18 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 162,786 | 2.84 | 462.3K | 162,786 | D | ↗ |
| 2025-06-18 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 162,786 | 2.84 | 462.3K | 162,786 | D | ↗ |
| 2025-06-18 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 162,786 | 2.84 | 462.3K | 162,786 | D | ↗ |
| 2025-06-18 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 162,786 | 2.84 | 462.3K | 162,786 | D | ↗ |
| 2025-02-22 | Simon Barry J. | Director | M-Exempt | D | Restricted Stock Units | 15,243 | 0.00 | — | 30,488 | D | ↗ |
| 2025-02-22 | Sachs David C. | Officer | F-InKind | D | Common Stock | 15,860 | 3.42 | 54.2K | 225,620 | D | ↗ |
| 2025-02-22 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 114,329 | 0.00 | — | 29,588,261 | D | ↗ |
| 2025-02-22 | LAUER REGAN J | Officer | M-Exempt | D | Restricted Stock Units | 4,065 | 0.00 | — | 8,130 | D | ↗ |
| 2025-02-22 | Adcock Richard | Director / Officer | M-Exempt | D | Restricted Stock Units | 152,439 | 0.00 | — | 304,878 | D | ↗ |
| 2025-02-10 | Sachs David C. | Officer | A-Award | A | Stock Option (right to buy) | 843,750 | 3.39 | 2.86M | 843,750 | D | ↗ |
| 2025-02-10 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 2,812,500 | 3.39 | 9.53M | 2,812,500 | D | ↗ |
| 2025-02-10 | LAUER REGAN J | Officer | A-Award | A | Stock Option (right to buy) | 56,250 | 3.39 | 190.7K | 56,250 | D | ↗ |
| 2025-02-10 | Adcock Richard | Director / Officer | A-Award | A | Restricted Stock Units | 822,368 | 0.00 | — | 822,368 | D | ↗ |
| 2025-01-22 | Simon Barry J. | Director | M-Exempt | A | Common Stock | 110,020 | 2.00 | 219.9K | 3,233,781 | D | ↗ |
| 2024-12-31 | Sachs David C. | Officer | M-Exempt | A | Common Stock | 30,397 | 0.00 | — | 216,235 | D | ↗ |
| 2024-12-31 | Adcock Richard | Director / Officer | M-Exempt | A | Common Stock | 34,483 | 0.00 | — | 277,621 | D | ↗ |
| 2024-12-15 | LAUER REGAN J | Officer | M-Exempt | A | Common Stock | 21,031 | 0.00 | — | 115,365 | D | ↗ |
| 2024-12-10 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | J-Other | D | Amended and Restated Promissory Note | 0 | 8.27 | — | 0 | I | ↗ |
| 2024-06-11 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-06-11 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-06-11 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-06-11 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-06-11 | Brennan John Owen | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-06-11 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 77,633 | 5.96 | 462.7K | 77,633 | — | ↗ |
| 2024-02-22 | Simon Barry J. | Director | A-Award | A | Restricted Stock Units | 45,731 | 0.00 | — | 45,731 | — | ↗ |
| 2024-02-22 | Sachs David C. | Officer | A-Award | A | Restricted Stock Units | 121,951 | 0.00 | — | 121,951 | — | ↗ |
| 2024-02-22 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | A-Award | A | Restricted Stock Units | 342,987 | 0.00 | — | 342,987 | — | ↗ |
| 2024-02-22 | LAUER REGAN J | Officer | A-Award | A | Restricted Stock Units | 12,195 | 0.00 | — | 12,195 | — | ↗ |
| 2024-02-22 | Adcock Richard | Director / Officer | A-Award | A | Restricted Stock Units | 457,317 | 0.00 | — | 457,317 | — | ↗ |
| 2024-02-05 | Adcock Richard | Director / Officer | M-Exempt | A | Common Stock | 83,334 | 0.00 | — | 286,303 | — | ↗ |
| 2024-01-31 | Simon Barry J. | Director | M-Exempt | D | Restricted Stock Units | 57,200 | 0.00 | — | 0 | — | ↗ |
| 2024-01-31 | Sachs David C. | Officer | F-InKind | D | Common Stock | 26,835 | 3.36 | 90.2K | 185,838 | — | ↗ |
| 2024-01-31 | LAUER REGAN J | Officer | M-Exempt | D | Restricted Stock Units | 32,872 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Sachs David C. | Officer | M-Exempt | A | Common Stock | 30,397 | 0.00 | — | 152,439 | — | ↗ |
| 2023-12-31 | Adcock Richard | Director / Officer | M-Exempt | A | Common Stock | 34,483 | 0.00 | — | 220,065 | — | ↗ |
| 2023-12-29 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | J-Other | A | Convertible Promissory Note | 0 | 2.28 | — | 0 | — | ↗ |
| 2023-12-15 | LAUER REGAN J | Officer | M-Exempt | A | Common Stock | 21,030 | 0.00 | — | 74,932 | — | ↗ |
| 2023-09-11 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | P-Purchase | A | Convertible Promissory Note | 0 | 1.94 | — | 0 | — | ↗ |
| 2023-09-01 | Simon Barry J. | Director | M-Exempt | A | Common Stock | 57,199 | 0.00 | — | 3,088,655 | — | ↗ |
| 2023-09-01 | Sachs David C. | Officer | M-Exempt | A | Common Stock | 70,744 | 0.00 | — | 122,042 | — | ↗ |
| 2023-09-01 | LAUER REGAN J | Officer | M-Exempt | A | Common Stock | 32,872 | 0.00 | — | 53,902 | — | ↗ |
| 2023-08-25 | Simon Barry J. | Director | A-Award | A | Restricted Stock Units | 114,399 | 0.00 | — | 114,399 | — | ↗ |
| 2023-08-25 | Sachs David C. | Officer | A-Award | A | Restricted Stock Units | 141,489 | 0.00 | — | 141,489 | — | ↗ |
| 2023-08-25 | LAUER REGAN J | Officer | A-Award | A | Restricted Stock Units | 65,744 | 0.00 | — | 65,744 | — | ↗ |
| 2023-06-15 | LAUER REGAN J | Officer | M-Exempt | D | Restricted Stock Units | 21,030 | 0.00 | — | 42,061 | — | ↗ |
| 2023-06-13 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-13 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-13 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-13 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-13 | Brennan John Owen | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-13 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 158,263 | 2.99 | 473.2K | 158,263 | — | ↗ |
| 2023-06-05 | BLASZYK MICHAEL D | Director | P-Purchase | A | Common Stock | 485 | 2.75 | 1.3K | 71,915 | — | ↗ |
| 2023-06-02 | Brennan John Owen | Director | P-Purchase | A | Common Stock | 5,000 | 2.74 | 13.7K | 5,000 | — | ↗ |
| 2023-06-01 | Clark Wesley | Director | P-Purchase | A | Common Stock | 7,000 | 2.91 | 20.4K | 8,000 | — | ↗ |
| 2023-05-12 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | P-Purchase | A | Convertible Promissory Note | 0 | 2.28 | — | 0 | — | ↗ |
| 2023-02-05 | Adcock Richard | Director / Officer | M-Exempt | A | Common Stock | 83,333 | 0.00 | — | 227,774 | — | ↗ |
| 2022-12-31 | Sachs David C. | Officer | M-Exempt | D | Restricted Stock Units | 7,598 | 0.00 | — | 136,793 | — | ↗ |
| 2022-12-31 | Adcock Richard | Officer | M-Exempt | D | Restricted Stock Units | 8,620 | 0.00 | — | 155,180 | — | ↗ |
| 2022-12-12 | SOON-SHIONG PATRICK | Officer | C-Conversion | D | Second Amended and Restated Convertible Promissory Note | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-31 | SOON-SHIONG PATRICK | Officer | P-Purchase | A | Second Amended and Restated Convertible Promissory Note | 0 | 40,016,261.00 | — | 0 | — | ↗ |
| 2022-06-14 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 0.00 | — | 167,937 | — | ↗ |
| 2022-06-14 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 2.98 | 500.5K | 167,937 | — | ↗ |
| 2022-06-14 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 0.00 | — | 167,937 | — | ↗ |
| 2022-06-14 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 0.00 | — | 167,937 | — | ↗ |
| 2022-06-14 | Brennan John Owen | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 0.00 | — | 167,937 | — | ↗ |
| 2022-06-14 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 167,937 | 0.00 | — | 167,937 | — | ↗ |
| 2022-03-23 | Simon Barry J. | Director | A-Award | A | Stock Option (right to buy) | 10,714 | 0.00 | — | 10,714 | — | ↗ |
| 2022-03-23 | Sachs David C. | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 0.00 | — | 125,000 | — | ↗ |
| 2022-03-23 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 350,000 | 5.83 | 2.04M | 350,000 | — | ↗ |
| 2022-03-23 | LAUER REGAN J | Officer | A-Award | A | Stock Option (right to buy) | 14,286 | 0.00 | — | 14,286 | — | ↗ |
| 2022-03-23 | Adcock Richard | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2022-02-05 | Adcock Richard | Director / Officer | M-Exempt | D | Restricted Stock Units | 83,333 | 0.00 | — | 166,667 | — | ↗ |
| 2021-12-31 | Thomas John C | — | — | I | Common Stock | 0 | 0.00 | — | 13,886 | — | ↗ |
| 2021-12-31 | Simon Barry J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-15 | LAUER REGAN J | Officer | A-Award | A | Restricted Stock Units | 63,091 | 0.00 | — | 63,091 | — | ↗ |
| 2021-12-09 | Sachs David C. | Officer | M-Exempt | D | Restricted Stock Units | 17,242 | 0.00 | — | 144,391 | — | ↗ |
| 2021-11-09 | LAUER REGAN J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-08 | Adcock Richard | Director / Officer | P-Purchase | A | Common Stock | 1,923 | 8.81 | 16.9K | 1,930 | — | ↗ |
| 2021-09-09 | Sachs David C. | Officer | M-Exempt | A | Common Stock | 7,598 | 0.00 | — | 26,458 | — | ↗ |
| 2021-09-09 | Adcock Richard | Director / Officer | F-InKind | D | Common Stock | 4,273 | 9.95 | 42.5K | 86,176 | — | ↗ |
| 2021-08-23 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 14,801 | 10.12 | 149.8K | 200,617 | — | ↗ |
| 2021-08-20 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 9,976 | 10.00 | 99.8K | 215,418 | — | ↗ |
| 2021-08-18 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 2,133 | 10.03 | 21.4K | 225,394 | — | ↗ |
| 2021-08-17 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 43,398 | 10.12 | 439.4K | 227,527 | — | ↗ |
| 2021-06-10 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | Brennan John Owen | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-06-10 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 26,064 | 14.91 | 388.6K | 26,064 | — | ↗ |
| 2021-05-25 | Simon Barry J. | Director | S-Sale | D | Common Stock | 88,787 | 16.18 | 1.44M | 3,102,507 | — | ↗ |
| 2021-05-24 | Simon Barry J. | Director | S-Sale | D | Common Stock | 21,223 | 16.02 | 340.1K | 3,191,294 | — | ↗ |
| 2021-05-21 | Simon Barry J. | Director | S-Sale | D | Common Stock | 14,990 | 16.09 | 241.2K | 3,212,517 | — | ↗ |
| 2021-05-05 | Simon Barry J. | Director | M-Exempt | A | Common Stock | 56,967 | 1.75 | 99.9K | 3,227,507 | — | ↗ |
| 2021-05-03 | Selecky Christobel | Director | A-Award | A | Stock Option (right to buy) | 21,873 | 17.24 | 377.1K | 21,873 | — | ↗ |
| 2021-05-03 | MAXWELL LINDA | Director | A-Award | A | Stock Option (right to buy) | 21,873 | 17.24 | 377.1K | 21,873 | — | ↗ |
| 2021-05-03 | Clark Wesley | Director | A-Award | A | Stock Option (right to buy) | 21,873 | 17.24 | 377.1K | 21,873 | — | ↗ |
| 2021-05-03 | Brennan John Owen | Director | A-Award | A | Stock Option (right to buy) | 21,873 | 17.24 | 377.1K | 21,873 | — | ↗ |
| 2021-03-29 | MAXWELL LINDA | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-09 | Selecky Christobel | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-09 | Sachs David C. | Officer | — | D | Restricted Stock Units | 169,231 | 0.00 | — | 0 | — | ↗ |
| 2021-03-09 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | J-Other | A | Common Stock | 5,723,182 | 0.00 | 572.32 | 29,473,932 | — | ↗ |
| 2021-03-09 | Clark Wesley | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-09 | Brennan John Owen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-09 | Adcock Richard | Director / Officer | J-Other | A | Restricted Stock Units | 172,420 | 0.00 | — | 172,420 | — | ↗ |
| 2021-02-05 | Simon Barry J. | Director / Officer | M-Exempt | A | Common Stock | 22,100 | 2.00 | 44.2K | 3,192,640 | — | ↗ |
| 2021-02-05 | Adcock Richard | Officer | A-Award | A | Stock Option (right to buy) | 750,000 | 23.72 | 17.79M | 750,000 | — | ↗ |
| 2021-02-02 | Simon Barry J. | Director / Officer | M-Exempt | A | Common Stock | 82,070 | 2.00 | 164.0K | 3,252,610 | — | ↗ |
| 2021-01-28 | Simon Barry J. | Director / Officer | S-Sale | D | Common Stock | 11,304 | 20.53 | 232.1K | 3,170,540 | — | ↗ |
| 2021-01-27 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 36,626 | 2.00 | 73.2K | 225,494 | — | ↗ |
| 2021-01-12 | Nelson Sonja | Officer | M-Exempt | D | Stock Option (right to buy) | 11,364 | 3.07 | 34.9K | 165,907 | — | ↗ |
| 2021-01-04 | Nelson Sonja | Officer | M-Exempt | D | Stock Option (right to buy) | 22,729 | 3.07 | 69.8K | 177,271 | — | ↗ |
| 2020-12-22 | Simon Barry J. | Director / Officer | S-Sale | D | Common Stock | 130,000 | 18.05 | 2.35M | 3,170,540 | — | ↗ |
| 2020-12-10 | Thomas John C | Director | S-Sale | D | Common Stock | 42,592 | 10.83 | 461.1K | 207,477 | — | ↗ |
| 2020-10-26 | Adcock Richard | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-19 | Thomas John C | Director | S-Sale | D | Common Stock | 20,000 | 9.19 | 183.8K | 250,069 | — | ↗ |
| 2020-08-13 | Thomas John C | Director | S-Sale | D | Common Stock | 20,000 | 9.34 | 186.8K | 270,069 | — | ↗ |
| 2020-08-11 | Thomas John C | Director | S-Sale | D | Common Stock | 210 | 10.55 | 2.2K | 310,069 | — | ↗ |
| 2020-08-11 | DRISCOLL FREDERICK W | Director | S-Sale | D | Common Stock | 50,000 | 10.22 | 511.2K | 124,535 | — | ↗ |
| 2020-08-11 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 30,000 | 9.96 | 298.8K | 270,925 | — | ↗ |
| 2020-08-02 | Nelson Sonja | Officer | M-Exempt | A | Common Stock | 10,000 | 0.00 | — | 40,410 | — | ↗ |
| 2020-07-21 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 1,565 | 2.00 | 3.1K | 392,120 | — | ↗ |
| 2020-07-20 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 87,705 | 2.00 | 175.3K | 393,685 | — | ↗ |
| 2020-07-08 | Simon Barry J. | Director / Officer | M-Exempt | A | Common Stock | 39,950 | 1.76 | 70.1K | 3,210,490 | — | ↗ |
| 2020-06-30 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 9 | 1.76 | 15.80 | 137,647 | — | ↗ |
| 2020-06-29 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,710,000 | 12.12 | 44.97M | 23,750,750 | — | ↗ |
| 2020-06-23 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 29,609 | 1.76 | 52.0K | 137,656 | — | ↗ |
| 2020-06-22 | Simon Barry J. | Director / Officer | M-Exempt | A | Common Stock | 136,729 | 1.76 | 240.0K | 3,327,235 | — | ↗ |
| 2020-06-19 | Simon Barry J. | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 9,337 | 1.76 | 16.4K | 303,994 | — | ↗ |
| 2020-06-10 | Thomas John C | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 6.21 | 621.0K | 100,000 | — | ↗ |
| 2020-06-10 | GORLIN STEVE | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 6.21 | 621.0K | 100,000 | — | ↗ |
| 2020-06-10 | DRISCOLL FREDERICK W | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 6.21 | 621.0K | 100,000 | — | ↗ |
| 2020-06-10 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 6.21 | 621.0K | 100,000 | — | ↗ |
| 2020-06-10 | BLASZYK MICHAEL D | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 6.21 | 621.0K | 100,000 | — | ↗ |
| 2020-05-27 | Simon Barry J. | Director / Officer | S-Sale | D | Common Stock | 75,000 | 7.56 | 567.3K | 3,194,906 | — | ↗ |
| 2020-05-21 | Simon Barry J. | Director / Officer | S-Sale | D | Common Stock | 36,932 | 5.52 | 203.7K | 3,269,906 | — | ↗ |
| 2020-05-11 | Simon Barry J. | Director / Officer | S-Sale | D | Common Stock | 28,068 | 5.50 | 154.5K | 3,306,838 | — | ↗ |
| 2020-03-23 | Nelson Sonja | Officer | F-InKind | D | Common Stock | 6,132 | 2.82 | 17.3K | 30,410 | — | ↗ |
| 2019-12-16 | Thomas John C | Director | S-Sale | D | Common Stock | 10,000 | 3.14 | 31.4K | 330,069 | — | ↗ |
| 2019-12-13 | Thomas John C | Director | S-Sale | D | Common Stock | 10,000 | 2.48 | 24.8K | 350,069 | — | ↗ |
| 2019-12-12 | Thomas John C | Director | S-Sale | D | Common Stock | 10,000 | 1.99 | 19.9K | 360,069 | — | ↗ |
| 2019-09-09 | Thomas John C | Director | S-Sale | D | Common Stock | 13,956 | 1.24 | 17.3K | 370,069 | — | ↗ |
| 2019-09-06 | Thomas John C | Director | S-Sale | D | Common Stock | 7,080 | 1.24 | 8.8K | 384,025 | — | ↗ |
| 2019-09-05 | Thomas John C | Director | S-Sale | D | Common Stock | 2,964 | 1.25 | 3.7K | 391,105 | — | ↗ |
| 2019-08-02 | Nelson Sonja | Officer | F-InKind | D | Common Stock | 3,458 | 1.27 | 4.4K | 21,542 | — | ↗ |
| 2019-06-06 | Thomas John C | Director | A-Award | A | Common Stock | 92,592 | 0.00 | — | 394,069 | — | ↗ |
| 2019-06-06 | GORLIN STEVE | Director | A-Award | A | Common Stock | 92,592 | 0.00 | — | 92,592 | — | ↗ |
| 2019-06-06 | DRISCOLL FREDERICK W | Director | A-Award | A | Common Stock | 92,592 | 0.00 | — | 174,535 | — | ↗ |
| 2019-06-06 | Cohen Cheryl | Director | A-Award | A | Common Stock | 300,925 | 0.00 | — | 300,925 | — | ↗ |
| 2019-06-06 | BLASZYK MICHAEL D | Director | A-Award | A | Common Stock | 92,592 | 0.00 | — | 193,667 | — | ↗ |
| 2019-03-21 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | O-OutOfTheMoney | D | Warrant (right to buy) | 17,589,250 | 2.00 | 35.15M | 0 | — | ↗ |
| 2018-11-29 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 138,349 | 1.65 | 228.3K | 0 | — | ↗ |
| 2018-11-28 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 17,140 | 1.76 | 30.1K | 172,368 | — | ↗ |
| 2018-11-27 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 100,000 | 1.75 | 175.2K | 189,508 | — | ↗ |
| 2018-11-23 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 9,312 | 2.01 | 18.7K | 289,508 | — | ↗ |
| 2018-11-21 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 22,900 | 2.02 | 46.2K | 298,820 | — | ↗ |
| 2018-11-14 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 115,930 | 2.21 | 255.7K | 0 | — | ↗ |
| 2018-11-13 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 33,300 | 2.40 | 79.9K | 115,930 | — | ↗ |
| 2018-11-12 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 47,050 | 2.43 | 114.5K | 149,230 | — | ↗ |
| 2018-08-27 | Simon Barry J. | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 3.07 | 614.0K | 200,000 | — | ↗ |
| 2018-08-27 | Nelson Sonja | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 3.07 | 614.0K | 200,000 | — | ↗ |
| 2018-08-27 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 18,300 | 3.09 | 56.5K | 196,280 | — | ↗ |
| 2018-08-24 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 10,225 | 3.07 | 31.3K | 214,580 | — | ↗ |
| 2018-08-23 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 21,475 | 3.06 | 65.7K | 224,805 | — | ↗ |
| 2018-08-02 | Nelson Sonja | Officer | A-Award | A | Restricted Stock Units | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2018-07-11 | SOON-SHIONG PATRICK | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 9,257 | 1.62 | 15.0K | 40,565,814 | — | ↗ |
| 2018-06-07 | Thomas John C | Director | A-Award | A | Common Stock | 27,322 | 0.00 | — | 301,477 | — | ↗ |
| 2018-06-07 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 26,957 | 3.66 | 98.6K | 321,720 | — | ↗ |
| 2018-06-07 | DRISCOLL FREDERICK W | Director | A-Award | A | Common Stock | 27,322 | 0.00 | — | 81,943 | — | ↗ |
| 2018-06-07 | BLASZYK MICHAEL D | Director | A-Award | A | Common Stock | 27,322 | 0.00 | — | 101,075 | — | ↗ |
| 2018-06-06 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 23,574 | 3.79 | 89.3K | 348,677 | — | ↗ |
| 2018-06-05 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 28,925 | 3.75 | 108.3K | 372,251 | — | ↗ |
| 2018-05-30 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 2,724 | 3.88 | 10.6K | 401,176 | — | ↗ |
| 2018-05-29 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 1,500 | 3.89 | 5.8K | 404,500 | — | ↗ |
| 2018-05-25 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 3,400 | 3.97 | 13.5K | 406,200 | — | ↗ |
| 2018-05-24 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 303 | 3.96 | 1.2K | 409,600 | — | ↗ |
| 2018-05-22 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 8,546 | 3.81 | 32.6K | 409,903 | — | ↗ |
| 2018-05-21 | GORLIN STEVE | Director | S-Sale | D | Common Stock | 5,557 | 4.00 | 22.2K | 418,449 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.6K
Shares Outstanding
1.05B
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Richard Adcock President and CEO | 831.7K | 141.7K | 2.79M | 8.35M | 485.2K | 117.2K | 12.72M | 87.61% | ↗ |
| 2 | 2025 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 648.8K | 110.5K | 2.79M | 8.35M | 378.5K | 14.2K | 12.29M | 90.63% | ↗ |
| 3 | 2025 | David Sachs CFO | 591.7K | 67.0K | 836.3K | 2.51M | 229.3K | 14.2K | 4.24M | 78.75% | ↗ |
| 4 | 2025 | Regan Lauer Chief Accounting Officer | 338.8K | 38.3K | 55.8K | 167.1K | 131.3K | 14.1K | 745.3K | 29.90% | ↗ |
| 5 | 2024 | Richard Adcock Chief Executive Officer and President | 802.1K | — | 2.40M | 7.21M | 477.6K | 64.0K | 10.95M | 87.73% | ↗ |
| 6 | 2024 | Richard Adcock President and CEO | 802.1K | — | 2.40M | 7.21M | 477.6K | 64.0K | 10.95M | 87.73% | ↗ |
| 7 | 2024 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 625.8K | — | 1.80M | 5.41M | 372.6K | 14.0K | 8.22M | 87.69% | ↗ |
| 8 | 2024 | David Sachs CFO | 574.5K | — | 639.0K | 1.92M | 230.1K | 14.0K | 3.38M | 75.79% | ↗ |
| 9 | 2024 | David Sachs Chief Financial Officer | 574.5K | — | 639.0K | 1.92M | 230.1K | 14.0K | 3.38M | 75.79% | ↗ |
| 10 | 2023 | Richard Adcock Chief Executive Officer and President | 796.0K | 298.5K | — | — | — | 62.4K | 1.16M | 0.00% | ↗ |
| 11 | 2023 | Richard Adcock President and CEO | 796.0K | 298.5K | — | — | — | 62.4K | 1.16M | 0.00% | ↗ |
| 12 | 2023 | David Sachs CFO | 537.5K | 274.0K | 233.5K | — | — | 13.1K | 1.06M | 22.06% | ↗ |
| 13 | 2023 | David Sachs Chief Financial Officer | 537.5K | 274.0K | 233.5K | — | — | 13.1K | 1.06M | 22.06% | ↗ |
| 14 | 2023 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 621.0K | 232.9K | — | — | — | 11.5K | 865.3K | 0.00% | ↗ |
| 15 | 2022 | Richard Adcock Chief Executive Officer and President | 790.8K | — | — | 3.16M | — | 58.7K | 4.01M | 78.81% | ↗ |
| 16 | 2022 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 617.0K | — | — | 3.16M | — | 12.2K | 3.79M | 83.39% | ↗ |
| 17 | 2022 | David Sachs Chief Financial Officer | 521.0K | — | — | 1.13M | — | 12.3K | 1.66M | 67.90% | ↗ |
| 18 | 2021 | Richard Adcock Chief Executive Officer and President | 765.1K | 57.7K | 13.87M | 13.97M | 269.1K | 82.7K | 29.02M | 95.95% | ↗ |
| 19 | 2021 | David Sachs Chief Financial Officer | 423.5K | 35.6K | 4.30M | — | 166.3K | 7.8K | 4.94M | 87.17% | ↗ |
| 20 | 2021 | Patrick Soon-Shiong Global Chief Scientific and Medical Officer | 237.7K | 45.0K | — | 300.6K | 210.0K | 46.6K | 839.9K | 35.79% | ↗ |
| 21 | 2021 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 237.7K | 45.0K | — | 300.6K | 210.0K | 46.6K | 839.9K | 35.79% | ↗ |
| 22 | 2020 | Barry J. Simon, M.D. President and Chief Administrative Officer | 456.2K | 173.2K | — | — | — | 30.3K | 659.7K | 0.00% | ↗ |
| 23 | 2020 | Patrick Soon-Shiong Global Chief Scientific and Medical Officer | 523.5K | 100.2K | — | — | — | 20.4K | 644.0K | 0.00% | ↗ |
| 24 | 2020 | Patrick Soon-Shiong, M.D. Global Chief Scientific and Medical Officer | 523.5K | 100.2K | — | — | — | 20.4K | 644.0K | 0.00% | ↗ |
| 25 | 2020 | David Sachs Chief Financial Officer | 443.0K | 193.5K | — | — | — | 7.1K | 643.6K | 0.00% | ↗ |
| 26 | 2020 | Sonja Nelson Chief Financial Officer | 364.5K | 119.0K | — | — | — | 24.5K | 508.0K | 0.00% | ↗ |
| 27 | 2020 | Patrick Soon-Shiong, M.D., FRCS , FACS Executive Chairman and Chief Executive Officer (until October 26, 2020) | 254.9K | 228.7K | — | — | — | 6.7K | 490.2K | 0.00% | ↗ |
| 28 | 2020 | Richard Adcock Chief Executive Officer and President | 141.3K | 67.8K | — | — | — | 1.7K | 210.9K | 0.00% | ↗ |
| 29 | 2020 | Richard Adcock Chief Executive Officer (appointed October 26, 2020) | 141.3K | — | — | — | — | 3.0K | 144.3K | 0.00% | ↗ |
| 30 | 2019 | Barry J. Simon, M.D. President and Chief Administrative Officer | 454.4K | — | — | — | — | 16.0K | 470.4K | 0.00% | ↗ |
| 31 | 2019 | Sonja Nelson Chief Financial Officer | 345.2K | 97.5K | — | — | — | 21.8K | 464.5K | 0.00% | ↗ |
| 32 | 2019 | Patrick Soon-Shiong, M.D., FRCS , FACS Executive Chairman and Chief Executive Officer (until October 26, 2020) | 320.4K | — | — | — | — | 11.2K | 331.6K | 0.00% | ↗ |
| 33 | 2019 | Patrick Soon-Shiong, M.D., FRCS , FACS Chairman and Chief Executive Officer | 320.4K | — | — | — | — | — | 320.4K | 0.00% | ↗ |
| 34 | 2018 | Barry J. Simon, M.D. President and Chief Administrative Officer | 454.4K | 149.8K | — | 418.0K | — | — | 1.02M | 40.89% | ↗ |
| 35 | 2018 | Barry J. Simon, M.D President and Chief Administrative Officer | 454.4K | 149.8K | — | 418.0K | — | — | 1.02M | 40.89% | ↗ |
| 36 | 2018 | Sonja Nelson Chief Financial Officer | 302.0K | 101.9K | 123.6K | 418.0K | — | — | 945.5K | 57.28% | ↗ |
| 37 | 2018 | Patrick Soon-Shiong, M.D., FRCS , FACS Chairman and Chief Executive Officer | 638.4K | 270.3K | — | — | — | — | 908.7K | 0.00% | ↗ |
| 38 | 2017 | Patrick Soon-Shiong, M.D., FRCS , FACS Chairman and Chief Executive Officer | 636.0K | — | — | — | — | — | 636.0K | 0.00% | ↗ |
| 39 | 2017 | Barry J. Simon, M.D. President and Chief Administrative Officer | 443.8K | — | — | — | — | — | 443.8K | 0.00% | ↗ |
| 40 | 2017 | Barry J. Simon, M.D President and Chief Administrative Officer | 443.8K | — | — | — | — | — | 443.8K | 0.00% | ↗ |
| 41 | 2017 | Richard Tajak Chief Financial Officer | 288.6K | — | — | — | — | — | 288.6K | 0.00% | ↗ |
| 42 | 2016 | Patrick Soon-Shiong, M.D., FRCS , FACS Chairman and Chief Executive Officer | 602.3K | — | — | — | — | — | 602.3K | 0.00% | ↗ |
| 43 | 2016 | Sonja Nelson Chief Accounting Officer | 167.3K | — | — | — | — | 329.1K | 496.4K | 0.00% | ↗ |
| 44 | 2016 | Barry J. Simon, M.D President and Chief Administrative Officer | 420.3K | — | — | — | — | — | 420.3K | 0.00% | ↗ |
| 45 | 2016 | Barry J. Simon, M.D. President and Chief Administrative Officer | 420.3K | — | — | — | — | — | 420.3K | 0.00% | ↗ |
| 46 | 2015 | Patrick Soon-Shiong, M.D., FRCS , FACS Chairman and Chief Executive Officer | 1.00 | 300.0K | 15.00M | 132.23M | — | — | 147.53M | 99.80% | ↗ |
| 47 | 2015 | Barry J. Simon, M.D President and Chief Administrative Officer | 417.8K | 177.8K | 9.26M | 11.40M | — | — | 21.25M | 97.20% | ↗ |
| 48 | 2015 | Barry J. Simon, M.D President and Chief Operating Officer | 417.8K | 177.8K | 9.26M | 11.40M | — | — | 21.25M | 97.20% | ↗ |
| 49 | 2015 | Angela Wilson Former Chief Financial Officer | 53.0K | — | 599.6K | — | — | 1.3K | 653.9K | 91.70% | ↗ |
| 50 | 2014 | Barry J. Simon, M.D President and Chief Operating Officer | 443.5K | 465.1K | — | 439.3K | — | 248.3K | 1.60M | 27.52% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard Gerald Adcock | President, Chief Executive Officer & Director | 2M | male |
| Patrick Soon-Shiong FRCS | Founder, Executive Chairman and Global Chief Scientific & Medical Officer | 1M | — |
| David C. Sachs | Chief Financial Officer | 902.2K | male |
| Regan J. Lauer | Chief Accounting Officer | 522.5K | female |
| Leonard S. Sender | Chief Medical Officer of Liquid Tumors & Cell Therapy | — | — |
| Manju Saxena | Senior Vice President of Product Development & Cell Therapy Program | — | — |
| Sandeep K. Reddy | Chief Medical Officer | — | — |
| Barry J. Simon | Chief Corporation Affairs Officer & Director | — | — |
| Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy | — | female |
| Emily Arison | Senior Vice President of Human Resources | — | female |
| Enrique Diloné | Chief Technology Officer | — | — |
| Hans Georg Klingemann | Chief Science Officer of Cellular | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-04-17 | Daniel Goldman | NY10 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IBRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
